Business Context and Reporting Period
This Form 6-K filing by Brainsway Ltd. is dated February 13, 2023, covering the month of February 2023. The filing serves to announce the scheduling of the Company's Annual Meeting of Shareholders, set for March 20, 2023, at 3:00 p.m. Israel time at the Company's principal executive office in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document notes a change in leadership roles for the signing of the report, listing Dr. David Zacut as the Departing Chairman and Ami Boehm as the Incoming Chairman.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It incorporates by reference the Notice and Proxy Statement (Exhibit 99.1) and Proxy Card (Exhibit 99.2) for the Annual Meeting, which are attached to the filing but not detailed in the text provided.
Key Facts for Investor Verification
- Annual Meeting of Shareholders is scheduled for March 20, 2023.
- Leadership transition is occurring with Dr. David Zacut departing as Chairman and Ami Boehm incoming.
- Investors should review the attached Exhibit 99.1 (Notice and Proxy Statement) for detailed agenda items and voting procedures.
- No financial performance data is included in this specific filing.